⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Orthocell Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Orthocell Limited
↗Murdoch, Australia
Orthocell Limited is a regenerative medicine company focused on the development and commercialization of biological medical devices and cell therapies to address unmet clinical needs in musculoskeletal disorders. The company specializes in regenerating mobility, function, and performance for patients suffering from soft tissue and bone injuries.
Orthocell's product portfolio includes Remplir™, a collagen-based nerve repair device, and Striate+™, a resorbable collagen membrane for dental applications. The company operates its own manufacturing facility in Perth, Western Australia, and has achieved regulatory approvals in multiple international jurisdictions, including US FDA 510(k) clearance for Remplir™.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Regenerative Medicine / Medical Devices
SIZE & FINANCIALS
Employees:51-200
Revenue:$5M-$10M
Founded:2006
Ownership:public
Status:operating
STOCK
Exchange:ASX
Ticker:OCC
Market Cap:$0.24B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Cell therapy, Collagen-based medical devices
Active Trials:0
Trial Phases:-
FDA Approvals:1
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Various global distribution partners for Remplir™ and Striate+™
COMPETITION
Position:Niche Player
Competitors:AxoGen Inc., Integra LifeSciences, Baxter International, Medtronic, Boston Scientific
LEADERSHIP
Key Executives:
Paul Anderson - CEO and Managing Director
Jim Piper - CFO
Adam Wood - Chief Commercial Officer
Scientific Founders:Paul Anderson, Ming Hao Zheng
Board Members:John Van Der Wielen, Fiona Wood, Ravi I. Thadhani
LINKS
Website:orthocell.com.au
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Orthocell Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.